Listar Artículos SCOPUS por autor "Asian Pacific Organization for Cancer Prevention"
Mostrando ítems 1-3 de 3
-
Diagnostic yield of primary circulating tumor cells in women suspected of breast cancer: The BEST (breast early screening test) study
Murray, Nigel P. [Chile. Universidad Mayor]; Miranda, Roxana [Chile. Universidad Mayor]; Ruiz, Amparo [Chile. Universidad Mayor]; Droguett, Elsa [Chile. Universidad Mayor] (Facultad de Ciencias, 2015)PURPOSE: To determine the diagnostic yield of primary circulating tumor cells in women with suspicion of breast cancer, detected as a result of an abnormal mammography. MATERIALS AND METHODS: Consecutive women presenting ... -
Predictive Value of Neutrophil to Lymphocyte Ratio in the Diagnosis of Significant Prostate Cancer at Initial Biopsy: A Comparison with Free Percent Prostate Specific Antigen, Prostate Specific Antigen Density and Primary Circulating Prostate Cells
Murray, Nigel P.; Fuentealba, Cynthia; Reyes, Eduardo; López, Marco Antonio; Salazar, Anibal; Minzer, Simona; Muñoz, Lorena; Orrego, Shenda; Guzman, Eghon [Chile. Universidad Mayor] (Chile. Universidad Mayor, 2019)Introduction: An elevated serum PSA is the only biomarker routinely used in screening for prostate cancer to indicate a prostate biopsy. However, it is not specific for prostate cancer and the neutrophil/lymphocyte ratio ... -
Prostate cancer screening in the fit chilean elderly: A head to head comparison of total serum PSA versus age adjusted PSA versus primary circulating prostate cells to detect prostate cancer at initial biopsy
Murray, Nigel P. [Chile. Universidad Mayor. Facultad de Medicina]; Reyes, Eduardo [Chile. Hospital DIPRECA]; Orellana, Nelson [Hospital de Carabineros de Chile]; Fuentealba, Chyntia [Hospital de Carabineros de Chile]; Jacob, Omar [Hospital de Carabineros de Chile] (Facultad de Ciencias, 2015)BACKGROUND: Prostate cancer is predominately a disease of older men, with a median age of diagnosis of 68 years and 71% of cancer deaths occurring in those over 75 years of age. While prostate cancer screening is not ...